Tandem Diabetes (TNDM) Tops Q2 EPS by 6c

Go back to Tandem Diabetes (TNDM) Tops Q2 EPS by 6c

Tandem Diabetes Care Reports Second Quarter 2015 Financial Results

July 30, 2015 4:30 PM EDT

SAN DIEGO, July 30, 2015 /PRNewswire/ -- Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the t:slim® and t:flex Insulin Pumps, today reported its financial results for the quarter ended June 30, 2015.

In comparing the second quarter of 2015 to the same period of 2014:

Sales grew 53 percent to $15.7 million from $10.3 million Total pump shipments grew 49 percent to 3,331 pumps from 2,235 pumps Operating margin improved to negative 119 percent from negative 179 percent

In comparing the first six months of 2015 to the same period of... More

Tandem Diabetes Care Announces Development Agreement with Dexcom for Integration of Future Generation CGM Systems

July 30, 2015 4:16 PM EDT

SAN DIEGO, July 30, 2015 /PRNewswire/ -- Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the t:slim® and t:flex Insulin Pumps, today announced that it has entered into non-exclusive Development Agreements with Dexcom, Inc. to allow the integration of future generation Tandem insulin pumps with the Dexcom G5 and G6 continuous glucose monitoring ("CGM") systems.

"Integrating Tandem's next generation pump platform with Dexcom's future CGM systems is an important step in aligning our technologies to be used in automated insulin delivery applications," said Kim Blickenstaff,... More